未找到相关数据
Glucocorticoids-associated depressive symptoms on systemic lupus erythematosus patients: A drug factor or, in fact, a need for psychological care
被引：0
作者：
Salles, Sue Ellen Dias
[1
]
Júnior, João Batista
[2
]
de Araujo Gaklik, Laura Thalita
[1
]
de Andrade, Socorro de Maria Ribeiro
[3
,4
]
Fernandes, Vander
[5
]
do Monte Arnaud, Adelita Duanra Medeiros
[1
,6
]
机构：
[1] College of Pharmacy, University of Cuiabá, Cuiabá, MT, Brazil
[2] College of Pharmacy, University Center of Federal District, Brasília, DF, Brazil
[3] College of Psychology, University of Cuiabá, Cuiabá, MT, Brazil
[4] Department of Psychology of the University of Cuiabá, General University Hospital, Cuiabá, MT, Brazil
[5] Department of Clinical Medicine, Rheumatology sector of the University of Cuiabá, General University Hospital, Cuiabá, MT, Brazil
[6] Immunological analysis sector, Clinical Analysis Laboratory, General University Hospital, Cuiabá, MT, Brazil
关键词：
Diseases;
-;
Hormones;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Systemic Lupus Erythematosus (SLE) is a chronic inflammatory disease of autoimmune nature, it can affects multiple organs and systems of unknown etiology, occurring more frequently in women of childbearing age and greater proportionality in relation to males. This study followed 57 patients suffering from SLE and assessed the possible therapeutic implications for use of glucocorticoids by these patients associated with depressive symptoms. From the data collected on the various drugs recommended for SLE patients' treatment, we found that about 80% of patients used at least one glucocorticoid. The results in our study demonstrate the relevance of depressive symptoms in SLE patients using glucocorticoids and thereby confirm that the pharmaceutical care, pharmacovigilance, and psychological care are of vital importance in conducting the safe and effective use of these drugs and in psychological support to these patients.
引用
收藏
页码：1005 / 1008
相关论文